Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 Antibody Responses in Immunosuppressed People (The MELODY Study)

NCT05148806 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05148806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05148806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 Antibody Responses in Immunosuppressed People (The MELODY Study)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
December 7, 2021
Completion date
December 30, 2022
Enrollment
28,411 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, haematological malignancies, solid organ transplant recipients